In patients with heart failure, iron deficiency is frequent but overlooked, with a prevalence of
30%–50%. Since it contributes to cardiac and peripheral muscle dysfunction, iron deficiency …

The prevalence of iron deficiency is high–even in the absence of anaemia–in patients with
chronic heart failure (HF). Although iron deficiency is easily diagnosed with two biomarkers …

Iron is a micronutrient essential for cellular energy and metabolism, necessary for
maintaining body homoeostasis. Iron deficiency is an important co-morbidity in patients with …

For patients with heart failure and reduced left ventricular ejection fraction, intravenous iron
is likely to deliver clinical and prognostic benefits for those with anaemia and transferrin …

Iron deficiency is a major heart failure co‐morbidity present in about 50% of patients with
stable heart failure irrespective of the left ventricular function. Along with compromise of daily …

Iron deficiency (ID) is one of the most frequent comorbidities in patients with heart failure
(HF). ID is estimated to be present in up to 50% of outpatients and is a strong independent …

Iron deficiency is an extremely common comorbidity in patients with heart failure, affecting
up to 50% of all ambulatory patients. It is associated with reduced exercise capacity and …

Iron is an essential micronutrient in many cellular processes. Iron deficiency, with or without
anaemia, is common in patients with chronic heart failure. Observational studies have …

Iron is an element necessary for cells due to its capacity of transporting oxygen and
electrons. One of the important co-morbidities in heart failure is iron deficiency. Iron has …

Iron deficiency is common in patients with chronic heart failure (CHF) and is associated with
reduced exercise performance, impaired health‐related quality of life and an increased risk …